Purchase Order 36C26326P0076

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) equipment and related cardiovascular medical devices. The contract, issued on October 31, 2025, with performance in Minneapolis, Minnesota, represents a non-set-aside procurement of specialized heart valve technology. Edwards Lifesciences LLC, a leading manufacturer of advanced cardiovascular medical devices and subsidiary of Edwards Lifesciences Corporation, serves as the prime contractor and sole source provider for these highly specialized implantable devices that support the VA's mission to deliver critical surgical interventions for veteran patients.

This purchase order falls under Edwards Lifesciences LLC's established relationship with the VA as a key supplier of transcatheter heart valve products. The company maintains broader indefinite delivery contracts with the VA valued at $3.75 million collectively, which enable the procurement of specialized cardiac devices including SAPIEN 3 and Inspiris Resilia valves on a consignment basis. The award reflects the VA's continued investment in advanced structural heart disease treatment capabilities across its integrated service networks, ensuring veterans have access to state-of-the-art cardiovascular surgical technologies with a contract completion target of November 30, 2025.